To meet the growing demand, medical manufacturing is adapting disruptive technologies that are reshaping manufacturing as a whole and displacing established practices. Here’s a look at some of the disruptive trends that are transforming medical manufacturing.
Following a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ brings you the pharma, biotech and life sciences news highlights for Q3 of 2016.
Currently, two trends are in focus for the clinical trial supply chain: patient centricity and the usage of the Internet of Things (IoT) in clinical trials. Both components are driven by the need to shorten clinical development timelines, reduce costs and improve data quality. The clinical supply chain can contribute significantly to these objectives.
Earlier this month, Industry members gathered to tackle challenges and contribute to the discussion surrounding cell and gene therapies and their manufacture.
A new technology referred to as an artificial nose has the ability to detect a rare progressive lung disease from a patient’s breath.
The first respiratory biomedicine from AstraZeneca received primary and key secondary endpoints in the third phase of clinical trials. The therapy, Benralizumab, when combined with standard medicine was seen to significantly reduce severity of asthma symptoms and enhanced lung function with individuals which harbour an eosinophilic phenotype.
G-PN is a new vaccine which is a whole cell pneumococcal treatment that is inactivated by the presence of gamma irradiation. This biologic is said to have the capability to eliminate all of the 90 known structures of the pneumococcus bacteria - Streptococcus pneumonia.
Remote working is exploding as a result of mobile technologies. A growing segment of the workforce prefers it, and it saves huge spend on real estate and related costs. But lagging behind the rapid technology expansion is well thought through organizational strategy to absolutely ensure that remote workers are as productive and as engaged as their in-house counterparts.
The world’s first cognitive computer. This is a device that can rapidly analyse the collective research and recommendations of leading professionals, in order to advise healthcare professionals and improve patient outcomes. To find out more, we speak with Dr James Miser, Chief Medical Information Officer at Bumrungrad International Hospital, who describes the implementation process so far and how the technology is likely to transform healthcare.
Safeguarding of information that the pharmaceutical industry disseminates via social media is essential. Although pharmaceutical industry websites contain a wealth of useful information, there appears to be a general apprehension in their use to disseminate medically relevant information